LUNG241220P10000
- 0.00
- 0.000.00%
Pulmonx Newsroom
Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect?
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
Pulmonx Partners With American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers
Alkermes, DaVita, Jabil, Ralph Lauren, Among Potential M&A Candidates - BofA
Stifel Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $16
Analyst Estimates: Here's What Brokers Think Of Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter Report
Pulmonx | 10-Q: Q3 2024 Earnings Report
Pulmonx Analyst Ratings
Stifel Maintains Pulmonx(LUNG.US) With Buy Rating, Cuts Target Price to $16
CCORF Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $16
Piper Sandler Maintains Pulmonx(LUNG.US) With Buy Rating, Cuts Target Price to $10
Pulmonx Corporation (LUNG) Q3 2024 Earnings Call Transcript Summary
Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates
Pulmonx GAAP EPS of $0.36 Beats by $0.81, Revenue of $20.4M Beats by $0.12M
Earnings Flash (LUNG) PULMONX CORPORATION Reports Q3 Revenue $20.4M
Pulmonx | 8-K: Pulmonx Reports Third Quarter 2024 Financial Results
Express News | Pulmonx Q3 Income From Operations USD -14.129 Million Vs. IBES Estimate USD -17.7 Million
Express News | Pulmonx Outlook FY Revenue USD 81-84 Million
Pulmonx 3Q Loss/Shr 36c >LUNG
Earnings Preview: Pulmonx to Report Financial Results Post-market on October 30